No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Established in 2002 and headquartered in Mumbai, India, Brooks Laboratories Limited operates as a pharmaceutical enterprise. The company focuses on the production and worldwide distribution of its medicinal offerings, serving both the Indian domestic market and international clientele. Its comprehensive product line features various dosage forms, such as liquid and dry powder injectable solutions, carbapenem-class drugs, oral tablets, dry-formulated syrups, and specialized ophthalmic and otic drops.
www.brookslabs.netNo one on the platform currently holds BROOKS.BO.
No tracked institution reports a position in BROOKS.BO as of their last filing.
No one on the platform has traded BROOKS.BO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| BROOKS.BOBrooks Laboratories Limited | $61.77 | -3.53% | $1.8B | — |
| AAREYDRUGS.NSAarey Drugs & Pharmaceuticals Limited | $98.17 | -0.66% | $2.8B | — |
| BAFNAPH.NSBafna Pharmaceuticals Limited | $308.25 | +0.31% | $7.3B | — |
| NECLIFE.BONectar Lifesciences Limited | $11.03 | -3.08% | $2.1B | — |
| NECLIFE.NSNectar Lifesciences Limited | $10.97 | -3.77% | $2.1B | — |
| TAKE.BOTAKE Solutions Limited | $18.00 | -3.43% | $2.6B | — |
| TAKE.NSTAKE Solutions Limited | $18.27 | -1.19% | $2.7B | — |
Source: Financial Modeling Prep · peers by sector/industry